Sionna Therapeutics, Inc.
SION
$39.46
$0.451.15%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | 20.29% | -111.27% | -39.12% | -33.45% | |
| Total Depreciation and Amortization | 11.83% | -11.45% | -4.22% | 3.73% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -67.68% | 504.47% | 83.66% | -33.22% | |
| Change in Net Operating Assets | 220.80% | -13.18% | 26.53% | 0.55% | |
| Cash from Operations | 13.89% | -78.94% | -23.63% | -58.09% | |
| Capital Expenditure | -- | -- | -- | 77.87% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 122.82% | 18.78% | -13.86% | 110.41% | |
| Cash from Investing | 121.99% | 18.78% | -13.93% | 113.64% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 2,604.11% | -- | 4,047,680.00% | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 298.19% | -921.05% | 11.61% | -- | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 218.98% | -7.70% | 1.53% | 729.32% | |